Nancy Butkiewicz

1.2k total citations
24 papers, 409 citations indexed

About

Nancy Butkiewicz is a scholar working on Hepatology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Nancy Butkiewicz has authored 24 papers receiving a total of 409 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hepatology, 13 papers in Infectious Diseases and 12 papers in Epidemiology. Recurrent topics in Nancy Butkiewicz's work include Hepatitis C virus research (19 papers), HIV/AIDS drug development and treatment (13 papers) and Hepatitis B Virus Studies (11 papers). Nancy Butkiewicz is often cited by papers focused on Hepatitis C virus research (19 papers), HIV/AIDS drug development and treatment (13 papers) and Hepatitis B Virus Studies (11 papers). Nancy Butkiewicz collaborates with scholars based in United States, United Kingdom and India. Nancy Butkiewicz's co-authors include John Pichardo, Viyyoor Girijavallabhan, F. George Njoroge, Andrew Prongay, Nanhua Yao, Vincent Madison, Kevin X. Chen, Ronald Jubin, Rumin Zhang and Johnson Y. N. Lau and has published in prestigious journals such as Journal of Virology, Biochemical and Biophysical Research Communications and Journal of Medicinal Chemistry.

In The Last Decade

Nancy Butkiewicz

23 papers receiving 366 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nancy Butkiewicz United States 14 221 148 131 118 99 24 409
John Pichardo United States 15 205 0.9× 120 0.8× 163 1.2× 146 1.2× 153 1.5× 30 458
Sandrine Vendeville France 11 135 0.6× 195 1.3× 184 1.4× 144 1.2× 174 1.8× 15 519
Darius Bilimoria Canada 10 320 1.4× 171 1.2× 161 1.2× 220 1.9× 55 0.6× 11 472
Anna Boguszewska‐Chachulska Poland 11 121 0.5× 98 0.7× 148 1.1× 99 0.8× 45 0.5× 26 369
Carrie A. Rutkowski United States 11 200 0.9× 138 0.9× 196 1.5× 295 2.5× 135 1.4× 13 518
Constantin G. Yannopoulos Canada 11 431 2.0× 229 1.5× 286 2.2× 290 2.5× 113 1.1× 12 732
Barbara Pacini Italy 8 163 0.7× 110 0.7× 104 0.8× 191 1.6× 89 0.9× 9 330
Shintaro Hirashima Japan 8 142 0.6× 71 0.5× 76 0.6× 99 0.8× 255 2.6× 8 428
Long V. Pham Denmark 13 188 0.9× 185 1.3× 141 1.1× 309 2.6× 29 0.3× 23 614
S. Benzaria France 11 171 0.8× 183 1.2× 335 2.6× 370 3.1× 139 1.4× 25 638

Countries citing papers authored by Nancy Butkiewicz

Since Specialization
Citations

This map shows the geographic impact of Nancy Butkiewicz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy Butkiewicz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy Butkiewicz more than expected).

Fields of papers citing papers by Nancy Butkiewicz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nancy Butkiewicz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy Butkiewicz. The network helps show where Nancy Butkiewicz may publish in the future.

Co-authorship network of co-authors of Nancy Butkiewicz

This figure shows the co-authorship network connecting the top 25 collaborators of Nancy Butkiewicz. A scholar is included among the top collaborators of Nancy Butkiewicz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nancy Butkiewicz. Nancy Butkiewicz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Kevin X., Bancha Vibulbhan, Weiying Yang, et al.. (2007). Potent and selective small molecule NS3 serine protease inhibitors of Hepatitis C virus with dichlorocyclopropylproline as P2 residue. Bioorganic & Medicinal Chemistry. 16(4). 1874–1883. 5 indexed citations
2.
Arasappan, Ashok, F. George Njoroge, Kevin X. Chen, et al.. (2006). P2–P4 Macrocyclic inhibitors of hepatitis C virus NS3-4A serine protease. Bioorganic & Medicinal Chemistry Letters. 16(15). 3960–3965. 16 indexed citations
3.
Venkatraman, Srikanth, F. George Njoroge, Wanli Wu, et al.. (2006). Novel inhibitors of hepatitis C NS3–NS4A serine protease derived from 2-aza-bicyclo[2.2.1]heptane-3-carboxylic acid. Bioorganic & Medicinal Chemistry Letters. 16(6). 1628–1632. 23 indexed citations
4.
Venkatraman, Srikanth, F. George Njoroge, Wanli Wu, et al.. (2006). Novel Inhibitors of Hepatitis C NS3—NS4A Serine Protease Derived from 2‐Aza‐bicyclo[2.2.1]heptane‐3‐carboxylic Acid.. ChemInform. 37(22). 1 indexed citations
5.
Bogen, Stéphane, Aparna Saksena, Ashok Arasappan, et al.. (2005). Hepatitis C virus NS3-4A serine protease inhibitors: Use of a P2–P1 cyclopropyl alanine combination for improved potency. Bioorganic & Medicinal Chemistry Letters. 15(20). 4515–4519. 16 indexed citations
6.
Bennett, Frank, Yi‐Tsung Liu, Anil K. Saksena, et al.. (2005). Novel inhibitors of the hepatitis C virus NS3 proteinase. Bioorganic & Medicinal Chemistry Letters. 15(19). 4275–4278. 2 indexed citations
7.
Venkatraman, Srikanth, F. George Njoroge, Viyyoor Girijavallabhan, et al.. (2005). Design and Synthesis of Depeptidized Macrocyclic Inhibitors of Hepatitis C NS3-4A Protease Using Structure-Based Drug Design. Journal of Medicinal Chemistry. 48(16). 5088–5091. 18 indexed citations
8.
Chen, Kevin X., F. George Njoroge, John Pichardo, et al.. (2005). Potent 7-Hydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic Acid-Based Macrocyclic Inhibitors of Hepatitis C Virus NS3 Protease. Journal of Medicinal Chemistry. 49(2). 567–574. 29 indexed citations
9.
Arasappan, Ashok, F. George Njoroge, John Pichardo, et al.. (2004). Novel 2-oxoimidazolidine-4-carboxylic acid derivatives as Hepatitis C virus NS3-4A serine protease inhibitors: synthesis, activity, and X-ray crystal structure of an enzyme inhibitor complex. Bioorganic & Medicinal Chemistry Letters. 14(23). 5751–5755. 11 indexed citations
10.
Shipps, Gerald W., Yongqi Deng, Tong Wang, et al.. (2004). Aminothiazole inhibitors of HCV RNA polymerase. Bioorganic & Medicinal Chemistry Letters. 15(1). 115–119. 12 indexed citations
11.
Hegde, Vinod R., Mahesh Patel, Pradip R. Das, et al.. (2003). Two antiviral compounds from the plant Stylogne cauliflora as inhibitors of HCV NS3 protease. Bioorganic & Medicinal Chemistry Letters. 13(17). 2925–2928. 29 indexed citations
12.
Jubin, Ronald, Michael G. Murray, Anita Y. M. Howe, et al.. (2000). Amantadine and Rimantadine Have No Direct Inhibitory Effects against Hepatitis C Viral Protease, Helicase, ATPase, Polymerase, and Internal Ribosomal Entry Site–Mediated Translation. The Journal of Infectious Diseases. 181(1). 331–334. 34 indexed citations
13.
Butkiewicz, Nancy, Nanhua Yao, Jacquelyn Wright-Minogue, et al.. (2000). Hepatitis C NS3 Protease: Restoration of NS4A Cofactor Activity by N-Biotinylation of Mutated NS4A Using Synthetic Peptides. Biochemical and Biophysical Research Communications. 267(1). 278–282. 5 indexed citations
14.
Butkiewicz, Nancy, Nanhua Yao, Weidong Zhong, et al.. (2000). Virus-Specific Cofactor Requirement and Chimeric Hepatitis C Virus/GB Virus B Nonstructural Protein 3. Journal of Virology. 74(9). 4291–4301. 36 indexed citations
15.
Wright-Minogue, Jacquelyn, Nanhua Yao, Rumin Zhang, et al.. (2000). Cross-genotypic interaction between hepatitis C virus NS3 protease domains and NS4A cofactors. Journal of Hepatology. 32(3). 497–504. 16 indexed citations
16.
Chu, Min, Ronald Mierzwa, Ling He, et al.. (1999). Isolation and structure of SCH 351633: a novel hepatitis C virus (HCV) NS3 protease inhibitor from the fungus Penicillium griseofulvum. Bioorganic & Medicinal Chemistry Letters. 9(14). 1949–1952. 14 indexed citations
17.
Bennett, Frank, et al.. (1998). Novel HIV- protease inhibitors containing β-hydroxyether and -thioether dipeptide isostere surrogates: modification of the P3 ligand. Bioorganic & Medicinal Chemistry Letters. 8(8). 931–934.
18.
19.
Chu, Min, Ronald Mierzwa, Imbi Truumees, et al.. (1996). Structure of Sch 68631: A new hepatitis C virus proteinase inhibitor from Streptomyces sp.. Tetrahedron Letters. 37(40). 7229–7232. 29 indexed citations
20.
Girijavallabhan, Viyyoor, Frank Bennett, Ashit K. Ganguly, et al.. (1994). The synthesis of novel HIV-protease inhibitors. Bioorganic & Medicinal Chemistry. 2(10). 1075–1083. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John Pichardo Breakdown of academic impact, for papers by Sandrine Vendeville Breakdown of academic impact, for papers by Darius Bilimoria Breakdown of academic impact, for papers by Anna Boguszewska‐Chachulska Breakdown of academic impact, for papers by Carrie A. Rutkowski Breakdown of academic impact, for papers by Constantin G. Yannopoulos Breakdown of academic impact, for papers by Barbara Pacini Breakdown of academic impact, for papers by Shintaro Hirashima Breakdown of academic impact, for papers by Long V. Pham Breakdown of academic impact, for papers by S. Benzaria
Rankless by CCL
2026